The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study compared the effect of indacaterol (300 μg once daily [od]) on exercise endurance
with that of placebo in patients with moderate to severe chronic obstructive pulmonary
disease.